Pyonephrosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Jose Loyola (talk | contribs) |
||
(4 intermediate revisions by 2 users not shown) | |||
Line 15: | Line 15: | ||
{{Pyonephrosis}} | {{Pyonephrosis}} | ||
'''For patient information page, click [[{{PAGENAME}} (patient information)|here]] | '''For patient information page, click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}};{{HVC}} | ||
{{SK}} Hydronephrosis, Infected | {{SK}} Hydronephrosis, Infected | ||
Line 26: | Line 26: | ||
==[[Pyonephrosis causes|Causes]]== | ==[[Pyonephrosis causes|Causes]]== | ||
==[[Pyonephrosis epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Pyonephrosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[Pyonephrosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
Line 41: | Line 43: | ||
==Related Chapters== | ==Related Chapters== | ||
*[[Pyelonephritis]] | *[[Pyelonephritis]] | ||
*[[Nephrotic syndrome]] | *[[Nephrotic syndrome]] |
Latest revision as of 00:49, 15 December 2021
Pyonephrosis | ||
ICD-10 | N13.6 | |
---|---|---|
ICD-9 | 590.8 | |
MeSH | C12.777.419.570.643.790 |
Pyonephrosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pyonephrosis On the Web |
American Roentgen Ray Society Images of Pyonephrosis |
For patient information page, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2];Harsh Vardhan Chawla, M.B.B.S.[3]
Synonyms and keywords: Hydronephrosis, Infected
Overview
Pathophysiology
Causes
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies